Page last updated: 2024-12-08

alpha-pyrrolidinopropiophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alpha-pyrrolidinopropiophenone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID209045
CHEBI ID180548
SCHEMBL ID11037118
MeSH IDM0469625

Synonyms (23)

Synonym
1-phenyl-2-pyrrolidin-1-ylpropan-1-one
CHEBI:180548
alpha-pyrrolidinopropiophenone
1-phenyl-2-(1-pyrrolidinyl)-1-propanone
1-propanone, 1-phenyl-2-(1-pyrrolidinyl)-
unii-01dp8ch58h
propiophenone, 2-(1-pyrrolidinyl)-
01dp8ch58h ,
19134-50-0
alpha-ppp
AKOS009049710
SCHEMBL11037118
a-pyrrolidinopropiophenone
KPUJAQRFIJAORQ-UHFFFAOYSA-N
J1.970.279K ,
.alpha.-pyrrolidino-propiophenone
.alpha.-pyrrolidinopropiophenone
.alpha.-ppp
1-phenyl-2-pyrrolidin-1-yl-propan-1-one
BCP07375
DTXSID50897462
Q4734920
PD048499

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Male, Swiss-Webster mice were exposed to α-PPP (80 mg/kg) using a binge-like dosing regimen (QID, q2h)."( Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice.
Blough, BE; Canal, CE; Chitre, NM; Daphney, CM; Murnane, KS; Ray, A, 2019
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (12.50%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]